Circulating Tumor DNA as a Prognostic Marker in Stage III Colon Cancer

被引：2

作者：

Zhao, Zhengyi ^{[1
]}

Cai, Shangli ^{[1
]}

Wang, Zhijie ^{[2
]}

机构：

[1] 3D Med Inc, Med Dept, Shanghai, Peoples R China

[2] Chinese Acad Med Sci & Peking Union Med Coll, State Key Lab Mol Oncol, Dept Med Oncol, Natl Canc Ctr,Canc Hosp, 17 Pan Jia Yuan S Ln, Beijing 100021, Peoples R China

来源：

JAMA ONCOLOGY | 2020年 / 6卷 / 06期

关键词：

D O I：

10.1001/jamaoncol.2020.0283

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：932 / 932

页数：1

共 50 条

[31] Circulating tumor DNA analysis guiding adjuvant therapy in stage II colon cancer
Israeli, Eitan
ISRAEL MEDICAL ASSOCIATION JOURNAL, 2022, 24 (07): : 481 - 481
[32] Prognostic Significance of Tumor Deposits in Patients With Stage III Colon Cancer: A Nomogram Study
Zheng, Peilin
Chen, Qiaoxing
Li, Jiake
Jin, Canguang
Kang, Lina
Chen, Donghan
JOURNAL OF SURGICAL RESEARCH, 2020, 245 : 475 - 482
[33] Circulating Tumor DNA Analysis Guiding Adjuvant Therapy in Stage II Colon Cancer
Tie, Jeanne
Cohen, Joshua D.
Lahouel, Kamel
Lo, Serigne N.
Wang, Yuxuan
Kosmider, Suzanne
Wong, Rachel
Shapiro, Jeremy
Lee, Margaret
Harris, Sam
Khattak, Adnan
Burge, Matthew
Harris, Marion
Lynam, James
Nott, Louise
Day, Fiona
Hayes, Theresa
McLachlan, Sue-Anne
Lee, Belinda
Ptak, Janine
Silliman, Natalie
Dobbyn, Lisa
Popoli, Maria
Hruban, Ralph
Lennon, Anne Marie
Papadopoulos, Nicholas
Kinzler, Kenneth W.
Vogelstein, Bert
Tomasetti, Cristian
Gibbs, Peter
NEW ENGLAND JOURNAL OF MEDICINE, 2022, 386 (24): : 2261 - 2272
[34] Prognostic significance of perioperative tumor marker levels in stage II/III gastric cancer
Suenaga, Yasuhito
Kanda, Mitsuro
Ito, Seiji
Mochizuki, Yoshinari
Teramoto, Hitoshi
Ishigure, Kiyoshi
Murai, Toshifumi
Asada, Takahiro
Ishiyama, Akiharu
Matsushita, Hidenobu
Tanaka, Chie
Kobayashi, Daisuke
Fujiwara, Michitaka
Murotani, Kenta
Kodera, Yasuhiro
WORLD JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2019, 11 (01) : 17 - 27
[35] Circulating tumor DNA as early marker of response to treatment in stage IV gastrointestinal cancer
Kirchweger, P.
Kupferthaler, A.
Burghofer, J.
Webersinke, G.
Jukic, E.
Schwendinger, S.
Fuegger, R.
Biebl, M.
Wundsam, H.
Rumpold, H.
ANNALS OF ONCOLOGY, 2022, 33 : S7 - S7
[36] Prognostic Significance of the Immunoscore in Colon Cancer in Stage III
Lorenz, Judith
ZEITSCHRIFT FUR GASTROENTEROLOGIE, 2021, 59 (02): : 114 - 114
[37] Tumor budding as a prognostic marker in stage III colorectal carcinoma
Choi, H. J.
Park, K. J.
Shin, J. S.
Roh, M. S.
Kwon, H. C.
Lee, H. S.
ISUCRS: PROCEEDINGS OF THE XXI BIENNIAL CONGRESS OF THE INTERNATIONAL SOCIETY OF UNIVERSITY COLON AND RECTAL SURGEONS, 2006, : 61 - +
[38] Circulating Tumor DNA as a Predictive Marker of Recurrence for Patients With Stage II-III Breast Cancer Treated With Neoadjuvant Therapy
Lin, Po-Han
Wang, Ming-Yang
Lo, Chiao
Tsai, Li-Wei
Yen, Tzu-Chun
Huang, Thomas Yoyan
Huang, Wei-Chih
Yang, Karen
Chen, Chih-Kai
Fan, Sheng-Chih
Kuo, Sung-Hsin
Huang, Chiun-Sheng
FRONTIERS IN ONCOLOGY, 2021, 11
[39] Prognostic utility of circulating tumor DNA methylation analysis in stage IV colorectal cancer
Momose, Hirotaka
Sugimoto, Kiichi
Irie, Takahiro
Nomura, Sachio
Ro, Hisashi
Ishiyama, Shun
Takahashi, Makoto
Pisanic, Thomas
Sakamoto, Kazuhiro
JOURNAL OF SURGICAL ONCOLOGY, 2024,
[40] Prognostic value of baseline circulating tumor cells (CTCs) enumerations is for stage III and stage IV breast cancer
Zhang, Qiang
Cai, Zheng
Gerratana, Lorenzo
D'Amico, Paolo
Davis, Andrew A.
Jacob, Saya Liz
Vagia, Elena
Shah, Ami N.
Flaum, Lisa
Zhang, Youbin
Qiang, Wenan
Wehbe, Firas
Behdad, Amir
Gradishar, William
Platanias, Leonidas C.
Cristofanilli, Massimo
CANCER RESEARCH, 2021, 81 (04)

← 1 2 3 4 5 →